Médicament Québec – October 2024
As part of its Innovations in Vaccine Technologies program, Médicament Québec (MQ) is accepting funding applications for innovative vaccine research activities. This program provides funding for activities conducted in academic settings and aims to stimulate and support initiatives that help strengthen Québec’s capacities in vaccine technologies or address critical needs within Québec’s vaccine ecosystem. Funded activities should lead to the development of platforms, tools, or other initiatives with societal impact, prospects for value creation, and/or long-term sustainability.
These activities must contribute to revitalizing the ecosystem within the themes outlined below. All proposed activities should be based on sound scientific principles, be structurally impactful and collaborative, and add value to the industrial sector. Projects must present an implementation plan to be completed within two years and have strong application potential. Selected projects should align with MQ’s mission, be of high quality, and demonstrate innovation.
📅 Deadline for submitting the Declaration of Interest: December 5, 2024
📅 Deadline for submitting the full application: February 4, 2025
| Development of tools or platforms to detect, anticipate, and prevent infectious threats |
| Development of methods to adapt infectious/anti-cancer vaccination |
| Development of tools or platforms to facilitate the discovery of new vaccines |
| Creation of tools or platforms to support analyses required for vaccines in development |
| Development of tools or platforms for clinical study design |
| Development of tools or platforms to facilitate the production of preclinical and clinical batches of vaccines |